Search results for: 'supplier development assessment'

The automotive industry is experiencing a significant transformation, transitioning from conventional to software-defined vehicles. As vehicles develop into intelligent, connected platforms driven by electrification, autonomous driving technologies, and digital services, traditional original equipment manufacturers (OEMs) are confronted with increa...

Insurtech risk assessment and analytics has grown because of the digitization of the insurance industry and the demand for online insurance products and secure data management. Companies in this segment leverage artificial intelligence (AI), machine learning (ML), and big data analytics to provide insurers with more accurate and actionable risk...

With persistent geopolitical tensions and the resultant trade fragmentation continuing to shape the global economy, policy priorities among countries advanced and emerging are shifting toward macroeconomic frameworks that will insulate them from external shocks. Incremental reforms that support sustainability and Industry 5.0 practices will have pr...

The global economy in recent years has faced a multitude of challenges such as the 2018 US-China Trade war, the 2020 COVID-19 pandemic, the 2022 Russo-Ukrainian war, as well as the recent 2023 Israel-Hamas war. These geopolitical upheavals have significantly impacted the socio-economic stability of countries across the world, with developed and eme...

Like most industries in 2024, technological advances, shifting consumer preferences, and regulatory changes are transforming the global automotive industry. Frost & Sullivan’s analysis shows that Chinese Tier 1 suppliers have emerged as pivotal players in this dynamic environment, leveraging their technological capabilities and innovative prowess t...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

The market landscape of Tier-I suppliers is going through a transformation. Connected cars is the fastest-growing segment in the overall automotive market, driven by new technology solutions, business models, and services. Partnerships, collaborations, and mergers and acquisitions (M&As) will accelerate, as the market moves toward software and serv...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...